Age, Biography and Wiki

Jeffrey Karp was born on 1976 in Massachusetts, is an engineer. Discover Jeffrey Karp's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 47 years old?

Popular As N/A
Occupation N/A
Age 47 years old
Zodiac Sign
Born 1976
Birthday 1976
Birthplace N/A
Nationality United States

We recommend you to check the complete list of Famous People born on 1976. He is a member of famous engineer with the age 47 years old group.

Jeffrey Karp Height, Weight & Measurements

At 47 years old, Jeffrey Karp height not available right now. We will update Jeffrey Karp's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Jeffrey Karp Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Jeffrey Karp worth at the age of 47 years old? Jeffrey Karp’s income source is mostly from being a successful engineer. He is from United States. We have estimated Jeffrey Karp's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income engineer

Jeffrey Karp Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2016

In 2016 the company Alivio Therapeutics was founded based on work by Langer and Karp on a hydrogel to deliver drugs, intended to stick to tissue and only release the drug in response to inflammation.

2015

In 2015 the company Frequency Therapeutics was founded to create treatments for hearing loss based on work done by Langer and Karp inspired by the ability of some amphibians and birds to regrow hair cells that have been damaged.

2014

In 2014 the company Skintifique was formed to commercialize a barrier cream Karp had invented to prevent skin reactions in people with nickel allergy.

2013

In 2013 the company Gecko Biomedical was founded based on the gecko adhesive work, as well as subsequent work done in the Karp lab based on secretions of sandcastle worms.

2008

Technology Review listed him in 2008 as one of the top innovators under the age of 35 (TR35). Karp received the 2011 Young Investigator award from the Society for Biomaterials, and also in 2011, the Boston Business Journal profiled him as a Champion in Health Care Innovation.

2007

In 2007 he received an appointment and his own lab at Brigham and Women’s Hospital, at a location near MIT; he retained his association with the Harvard–MIT HST program. He has made mentoring high school students, undergraduates, PhD students, and post docs a priority, and in 2008 he won the Outstanding Undergraduate Student Mentor Award at MIT, and in 2010 he won the Thomas A. McMahon Mentoring Award from the HST program.

2004

He received a Ph.D. in Chemical and Biomedical Engineering from the University of Toronto in 2004.

From 2004 until 2006, Karp was a postdoctoral fellow in Robert Langer's laboratory at MIT in the Harvard–MIT Program of Health Sciences and Technology; Karp had applied for the position but Langer had no funds to pay him, so Karp secured funding from the Natural Sciences and Engineering Research Council and Langer accepted him.

1999

Karp was born and raised in Peterborough, Ontario. He graduated from McGill University in 1999 with a degree in chemical engineering. While at McGill he also co-founded the McGill Engineering Code of Ethics "The Blueprint".

1975

Jeffrey Karp (born 1975) is a Canadian biomedical engineer working as a Professor of Medicine at Harvard Medical School, Brigham and Women's Hospital, and the principal faculty at the Harvard Stem Cell Institute and Affiliate Faculty at the Massachusetts Institute of Technology through the Harvard–MIT Division of Health Sciences and Technology. He is also an affiliate faculty at the Broad Institute.